Asia Pacific Diabetes Care Devices Market Forecast to 2028

Asia Pacific Diabetes Care Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Glucose Monitoring Devices and Insulin Delivery Devices) and End User (Homecare and Hospitals & Clinics)

Report Code : TIPRE00005736 | Region : Asia Pacific | Industry : Medical Device | Published Date : 10/Aug/2022

The APAC diabetes care devices market is expected to grow from US$ 6,350.97 million in 2022 to US$ 9,554.90 million by 2028; it is estimated to grow at a CAGR of 5.2% from 2022 to 2028.

Technological advancements in the healthcare industry are encouraging market players to focus on research and development of insulin delivery devices. There are various methods to deliver insulin into the human body, including needles, insulin pens, and insulin pumps. Insulin pumps are small computerized diabetes management devices connected with a cannula under the skin to deliver a slow and continuous insulin level. Optimal diabetes management depends on accurate glucose monitoring devices. Technological advancements in glucose monitoring devices have resulted in smaller requirements for blood samples with improved accuracy. Furthermore, the ability to transfer data between the blood glucose (BG) meter and insulin delivery devices has been improved. A smart insulin pen is a reusable injector pen with an easy-to-use smartphone app that can assist diabetic people in managing insulin delivery. This intelligent device calculates and tracks doses while also providing patients with helpful reminders. In November 2020, Medtronic plc launched InPen, which relates to real-time Guardian Connect CGM data. The continuous research in insulin pens supports the growth of the diabetes care devices market during the forecast period. Pen needles and syringes are the most used device for injecting insulin into diabetic patients. Various manufacturers are developing innovative products to sustain in the highly fragmented needle market. Moreover, the easy regulatory approvals have led to mid-sized companies entering the market and competing with the local and established players. The development of pen needles with precise lubrication to reduce the pain sensation has been another focus of manufacturers during the research. Thus, the technological advancements and the increasing influx of new products into the market are expected to propel the growth of the market over the forecast years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC diabetes care devices market. The APAC diabetes care devices market is expected to grow at a good CAGR during the forecast period.

APAC Diabetes Care Devices Market Revenue and Forecast to 2028 (US$ Million)

APAC Diabetes Care Devices Market Segmentation

The APAC diabetes care devices market is segmented based on type, end user, and country. Based on type, the market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment would dominate the market in 2022. The glucose monitoring devices segment is further categorized into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is segmented into insulin pens, insulin syringes, insulin pumps, and others. Based on end user, the APAC diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment would dominate the market in 2022. Based on country, the APAC diabetes care devices market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of APAC. China would dominate the market in 2022.

B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation are among the leading companies in the APAC diabetes care devices market.

At 5.2% CAGR, the APAC Diabetes Care Devices Market is speculated to be worth US$ 9,554.90 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the APAC diabetes care devices market was valued at US$ 6,350.97 million in 2022 and is expected to reach US$ 9,554.90 million by 2028, registering an annual growth rate of 5.2% from 2022 to 2028. Growing medical tourism in developing countries and rapid technological advancements in diabetes care devices are the critical factors attributed to the market expansion.

The emerging markets in the developing countries provide better opportunities for major players to expand their business. Many diabetes care device market players are focusing on the emerging market in the region due to an increase in the prevalence of diabetes and the growing use of diabetes care devices. In the emerging countries, medical science has grown rapidly in the past few decades. Furthermore, diabetes treatment has become so popular and common that people are travelling in developing countries for treatment. This is due to excessively high expenses for healthcare in other countries. For instance, health travelers who visit developing countries for medical reasons save 65-80% on health costs compared to the cost in the developed countries. Due to several other factors, diabetes treatment has become very cheap in developing countries. Further, government authorities in countries in the region are focusing on strengthening their medical tourism sector, thereby maximizing the flow of revenue. Therefore, the rising medical tourism in developing nations is anticipated to provide lucrative growth opportunities to players operating in the diabetes care devices market during the forecast period across the region.

On the contrary, high cost of diabetes care devices hurdles the growth of APAC diabetes care devices market.

Based on type, the APAC diabetes care devices market is bifurcated into glucose monitoring devices and insulin delivery devices. The glucose monitoring devices segment held 54.6% market share in 2022, amassing US$ 3,470.23 million. It is projected to garner US$ 5,308.93 million by 2028 to expand at 5.5% CAGR during 2022–2028. The glucose monitoring devices segment is further segmented into testing strips, glucometer, lancets, and others. Similarly, the insulin delivery devices segment is segmented into insulin pens, insulin syringes, insulin pumps, and others.

Based on end user, the APAC diabetes care devices market is bifurcated into homecare and hospitals & clinics. The homecare segment held 60.3% market share in 2022, amassing US$ 3,827.55 million. It is projected to garner US$ 5,829.65 million by 2028 to expand at 5.4% CAGR during 2022–2028.

Based on country, the APAC diabetes care devices market has been categorized into China, India, Japan, South Korea, Australia, and rest of APAC. Our regional analysis states that China captured 29.7% market share in 2022. It was assessed at US$ 1,885.44 million in 2022 and is likely to hit US$ 2,883.39 million by 2028, exhibiting a CAGR of 5.5% during the forecast period.

Key players dominating the APAC diabetes care devices market are B. Braun Melsungen AG; BD; Dexcom, Inc.; Eli Lilly and Company.; F. Hoffmann-La Roche Ltd.; Insulet Corporation; Medtronic; Novo Nordisk A/S; Tandem Diabetes Care Inc.; and Terumo Corporation among others.

In Feb 2022, Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand of products, is celebrating representation and inclusion for the diabetes community through an activation in the popular Nintendo video game Animal Crossing: New Horizons. In May 2022, Roche Diabetes Care India announced the launch of Accu-Fine, quality pen needles to make the process of insulin delivery smoother and virtually painless for people with diabetes. This latest innovation from (Roche Diabetes Care, maker of Accu-Chek) the house of Accu-Chek aims to make making the process of insulin delivery easier thereby leading to better diabetes management for people with diabetes.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Diabetes Care Devices Market – By Type

1.3.2 APAC Diabetes Care Devices Market – By End User

1.3.3 APAC Diabetes Care Devices Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Diabetes Care Devices Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Expert Opinion

5. APAC Diabetes Care Devices Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Incidence of Diabetes

5.1.2 Growing Geriatric Population

5.2 Market Restraints

5.2.1 High Cost of Diabetes Care Devices

5.3 Market Opportunities

5.3.1 Escalating Medical Tourism in Developing Countries

5.4 Future Trends

5.4.1 Growing Technological Advancements in Diabetes Care Devices

5.5 Impact Analysis

6. Diabetes Care Devices Market– APAC Analysis

6.1 APAC Diabetes Care Devices Market Revenue Forecast and Analysis

7. APAC Diabetes Care Devices Market Analysis – By Type

7.1 Overview

7.2 APAC Diabetes Care Devices Market Revenue and Forecasts Analysis, By Type (US$ Mn)

7.3 Glucose Monitoring Devices Market

7.3.1 Overview

7.3.2 Glucose Monitoring Devices Market Revenue and Forecast to 2028 (US$ Mn)

7.3.3 Testing Strips Market

7.3.3.1 Overview

7.3.3.2 Testing Strips Market Revenue and Forecast to 2028 (US$ Mn)

7.3.4 Glucometers Market

7.3.4.1 Overview

7.3.4.2 Glucometers Market Revenue and Forecast to 2028 (US$ Mn)

7.3.5 Lancets Market

7.3.5.1 Overview

7.3.5.2 Lancets Market Revenue and Forecast to 2028 (US$ Mn)

7.3.7 Other Glucose Monitoring Devices Market

7.3.7.1 Overview

7.3.7.2 Other Glucose Monitoring Devices Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Insulin Delivery Devices Market

7.4.1 Overview

7.4.2 Insulin Delivery Devices Market Revenue and Forecast to 2028 (US$ Mn)

7.4.3 Insulin Pens Market

7.4.3.1 Overview

7.4.3.2 Insulin Pens Market Revenue and Forecast to 2028 (US$ Mn)

7.4.4 Insulin Syringes Market

7.4.4.1 Overview

7.4.4.2 Insulin Syringes Market Revenue and Forecast to 2028 (US$ Mn)

7.4.5 Insulin Pumps Market

7.4.5.1 Overview

7.4.5.2 Insulin Pumps Market Revenue and Forecast to 2028 (US$ Mn)

7.4.6 Other Insulin Delivery Devices Market

7.4.6.1 Overview

7.4.6.2 Other Insulin Delivery Devices Market Revenue and Forecast to 2028 (US$ Mn)

8. APAC Diabetes Care Devices Market Analysis– By End User

8.1 Overview

8.2 APAC Diabetes Care Devices Market Revenue and Forecasts Analysis, By End User (US$ Mn)

8.3 Homecare Market

8.3.1 Overview

8.3.2 Homecare Market Revenue and Forecasts to 2028 (US$ Mn)

8.4 Hospitals & Clinics Market

8.4.1 Overview

8.4.2 Hospitals & Clinics Market Revenue and Forecasts to 2028 (US$ Mn)

9. APAC Diabetes Care Devices Market – Country Analysis

9.1 APAC: Diabetes Care Devices Market

9.1.1 Overview

9.1.2 APAC: Diabetes Care Devices Market, by Country, 2022 & 2028 (%)

9.1.2.1 China: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.1 Overview

9.1.2.1.2 China: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.3 China: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

9.1.2.1.3.1 China: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

9.1.2.1.3.2 China: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

9.1.2.1.4 China: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

9.1.2.2 Japan: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.1 Overview

9.1.2.2.2 Japan: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.3 Japan: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

9.1.2.2.3.1 Japan: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

9.1.2.2.3.2 Japan: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

9.1.2.2.4 Japan: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

9.1.2.3 India: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.1 Overview

9.1.2.3.2 India: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.3 India: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

9.1.2.3.3.1 India: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

9.1.2.3.3.2 India: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

9.1.2.3.4 India: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

9.1.2.4 South Korea: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.1 Overview

9.1.2.4.2 South Korea: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.3 South Korea: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

9.1.2.4.3.1 South Korea: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

9.1.2.4.3.2 South Korea: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

9.1.2.4.4 South Korea: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

9.1.2.5 Australia: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.1 Overview

9.1.2.5.2 Australia: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.3 Australia: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

9.1.2.5.3.1 Australia: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

9.1.2.5.3.2 Australia: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

9.1.2.5.4 Australia: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

9.1.2.6 Rest of APAC: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.1 Overview

9.1.2.6.2 Rest of APAC: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.3 Rest of APAC: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

9.1.2.6.3.1 Rest of APAC: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

9.1.2.6.3.2 Rest of APAC: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

9.1.2.6.4 Rest of APAC: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

10. Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 BD

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Novo Nordisk A/S

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 B. Braun Melsungen AG

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Medtronic

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 Tandem Diabetes Care Inc.

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Insulet Corporation

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

11.7 Eli Lilly and Company.

11.7.1 Key Facts

11.7.2 Business Description

11.7.3 Products and Services

11.7.4 Financial Overview

11.7.5 SWOT Analysis

11.7.6 Key Developments

11.8 Dexcom, Inc.

11.8.1 Key Facts

11.8.2 Business Description

11.8.3 Products and Services

11.8.4 Financial Overview

11.8.5 SWOT Analysis

11.8.6 Key Developments

11.9 Terumo Corporation

11.9.1 Key Facts

11.9.2 Business Description

11.9.3 Products and Services

11.9.4 Financial Overview

11.9.5 SWOT Analysis

11.9.6 Key Developments

11.10 F. Hoffmann-La Roche Ltd.

11.10.1 Key Facts

11.10.2 Business Description

11.10.3 Products and Services

11.10.4 Financial Overview

11.10.5 SWOT Analysis

11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners

12.2 Glossary of Terms

LIST OF TABLES.

Table 1.             APAC Diabetes Care Devices Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             China US: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

Table 3.             China: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

Table 4.             China: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

Table 5.             China: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

Table 6.             Japan: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

Table 7.             Japan: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

Table 8.             Japan: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

Table 9.             Japan: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

Table 10.          India: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

Table 11.          India: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

Table 12.          India: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

Table 13.          India: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

Table 14.          South Korea: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

Table 15.          South Korea: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

Table 16.          South Korea: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

Table 17.          South Korea: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

Table 18.          Australia: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

Table 19.          Australia: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

Table 20.          Australia: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

Table 21.          Australia: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

Table 22.          Rest of APAC: Diabetes Care Devices Market, by Type, 2019–2028 (USD Million)

Table 23.          Rest of APAC: Diabetes Care Devices Market, by Glucose Monitoring Devices Type, 2019–2028 (USD Million)

Table 24.          Rest of APAC: Diabetes Care Devices Market, by Insulin Delivery Devices Type, 2019–2028 (USD Million)

Table 25.          Rest of APAC: Diabetes Care Devices Market, by End User, 2019–2028 (USD Million)

Table 26.          Organic Developments Done By Companies

Table 27.          Inorganic Developments Done By Companies

Table 28.          Glossary of Terms

LIST OF FIGURES.

Figure 1.           APAC Diabetes Care Devices Market Segmentation

Figure 2.           APAC Diabetes Care Devices Market Segmentation, By Country

Figure 3.           APAC Diabetes Care Devices Market Overview

Figure 4.           APAC Diabetes Care Devices Market, By Type

Figure 5.           APAC Diabetes Care Devices Market, By Country

Figure 7.           APAC: PEST Analysis

Figure 8.           Experts’ Opinion

Figure 9.           APAC Diabetes Care Devices Market: Impact Analysis of Drivers and Restraints

Figure 10.        APAC Diabetes Care Devices Market– Revenue Forecast and Analysis

Figure 11.        APAC Diabetes Care Devices Market Revenue and Forecast Analysis, By Type 2022 and 2028 (%)

Figure 12.        APAC Glucose Monitoring Devices Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        APAC Testing Strips Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        APAC Glucometers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        APAC Lancets Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        APAC Other Glucose Monitoring Devices Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        APAC Insulin Delivery Devices Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        APAC Insulin Pens Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        APAC Insulin Syringes Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        APAC Insulin Pumps Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        APAC Others Insulin Delivery Devices Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        APAC Diabetes Care Devices Market Revenue and Forecast Analysis, by End User 2022 & 2028 (%)

Figure 23.        APAC Homecare Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        APAC Hospitals & Clinics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        APAC: Diabetes Care Devices Market, by Key Country – Revenue (2022) (USD Million)

Figure 26.        APAC: Diabetes Care Devices Market, by Country, 2022 & 2028 (%)

Figure 27.        China: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        Japan: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        India: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        South Korea: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Australia: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Rest of APAC: Diabetes Care Devices Market – Revenue and Forecast to 2028 (USD Million)

The List of Companies - Asia Pacific Diabetes Care Devices Market

● B. Braun Melsungen AG

● BD

● Dexcom, Inc.

● Eli Lilly and Company.

● F. Hoffmann-La Roche Ltd.

● Insulet Corporation

● Medtronic    

● Novo Nordisk A/S

● Tandem Diabetes Care Inc.

● Terumo Corporation

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC diabetes care devices market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the APAC diabetes care devices market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the diabetes care devices market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP